Search results for

A new NPR/Ipsos poll finds about 6 in 10 Americans are opposed to training teachers to carry guns in schools. But two-thirds of Republicans, including 71 percent of Republican men, are in favor of it.

The argument over the vice president's role in counting electoral votes fueled the Jan. 6 protests, thanks to ambiguity in the Electoral Count Act. A push to clarify the law is gaining traction.

Recreational marijuana will be available in Missouri as early as Feb. 6, 2023. While many details aren’t completely set in stone, here's what we know right now about buying legal weed.

Days ahead of midterm elections, President Biden is giving his closing argument on the state of U.S. democracy with the backdrop of the U.S. Capitol, where the Jan. 6 attack took place.

Jeremy Richman spoke openly and often about the depth of his grief over the death of his 6-year-old daughter, Avielle. He said he wanted people to "hear the reality of it."

U.S. Transportation Secretary Pete Buttiegieg said $196 million will go toward replacing 48 MetroLink light rail cars. The funding is one of the biggest grants MetroLink has received.

Don Siegelman wants the Alabama governorship back. First, he has to get by a tough opponent, Lucy Baxley, in the June 6 Democratic primary. And there's one more thing: He faces trial on corruption charges.

In a moment some have looked forward to for more than 50 years, the presidents of the U.S. and Cuba met at the annual Summit of the Americas.

A small Canadian firm takes on two of the largest drug companies in the world with its surprise launch of a generic copy of the best-selling blood thinner Plavis. Apotex began shipping its generic version to U.S. stores today. The makers of Plavix sold $6 billion of the popular heart drug last year.

Yahoo is rejecting an unsolicited $44.6 billion offer from Microsoft. But it remains to be seen whether Yahoo shareholders will support a management decision to snub the software giant's bid.